|
| Analyst
Scorecard | | Analyst: | Nachman, Gary | EPS
Est. Accuracy: | 
| | Broker: | Leerink Swann Llc | Recommendation
Performance: | Not Avl.
|
|
What is this?
This scorecard presents a summary of StarMine ratings
for this analyst.
Ratings are displayed when analysts score highly based
on the accuracy of
their earnings estimates or the returns of their stock
recommendations. Stocks
which appear on this scorecard are limited to those
covered by the analyst for
a significant period of time. Learn
More
|
| |
Industry Coverage
| | |
Industry
|
EPS Est. Accuracy
|
Industry Excess Return
|
Industry Return
| | | |
Pharmaceuticals
|
|
2.2%
| Not Avl.
| | | |
| |
EPS Estimate Accuracy
| | |
Symbol
|
Company Name
|
EPS Est. Accuracy
|
No. Analysts
| | | |
AGN
|
Allergan Inc
| 
|
16
| | | | |
CEPH
|
Cephalon Inc
|
|
24
| | | | |
ENDP
|
Endo Pharmaceuticals
|
|
21
| | | | |
FRX
|
Forest Laboratories Inc
|
|
20
| | | | |
JAV
|
Javelin Pharmaceuticals Inc
|
|
3
| | | | |
JAZZ
|
Jazz Pharmaceuticals Inc
|
|
4
| | | | |
MRX
|
Medicis Pharmaceutical Corp
|
|
15
| | | | |
SCMP
|
Sucampo Pharmaceuticals Inc
|
|
4
| | | |
| Other Stocks Covered
| |
Cadence Pharmaceuticals Inc (CADX), Cynosure Inc (CYNO), King Pharmaceuticals (KG), Valeant Pharma (VRX), Warner Chilcott Ltd (WCRX)
|
| | |
|
|
|